Featured Research

from universities, journals, and other organizations

USC Teams Battle HIV Drug Resistance

Date:
March 16, 2005
Source:
University Of Southern California
Summary:
Despite medicine’s growing arsenal of potent therapies against HIV, some HIV patients become resistant to drugs — often because they cannot keep up with demanding drug regimens. As a result, physicians such as Kathleen Squires, associate professor of medicine in the Keck School of Medicine of USC, now work with counseling teams that help patients adhere to their schedules.

USC's Kathleen Squires, an expert on antiretroviral drug development, briefs the media on team-based strategies to support HIV drug regimen adherence.
Credit: Photo /American Medical Association

Despite medicine’s growing arsenal of potent therapies against HIV, some HIV patients become resistant to drugs — often because they cannot keep up with demanding drug regimens.

Related Articles


As a result, physicians such as Kathleen Squires, associate professor of medicine in the Keck School of Medicine of USC, now work with counseling teams that help patients adhere to their schedules.

Squires, an expert in antiretroviral drug development and issues related to HIV infection, spoke about the adherence teams at an American Medical Association media briefing called “HIV/AIDS: The Drug Resistance Epidemic,” recently held in New York City.

Anti-viral drugs slow down the reproduction of HIV in the body. But HIV can change slightly as it reproduces, and sometimes the changes allow it to escape the virus-fighting effects of drugs — making new strains more drug resistant.

The more tightly patients adhere to their drug regimens, the more these patients can keep the virus under control; going off their schedules may give HIV a greater chance to reproduce and create resistant strains.

For each patient who becomes drug resistant, health-care professionals must work together to understand the challenges faced by that patient, said Squires, medical director of the LAC+USC Medical Center HIV/AIDS clinic, or “5P21,” one of the nation’s largest AIDS clinics.

“We assign a core team to work with a person who has anti-HIV drug resistance, including a physician assistant, nurse and a social worker,” Squires said. “We want to get to the root of the problem and understand how adherence became a problem for the person.

“In some cases, we will provide an adherence counselor offering either group or individual counseling at a variety of locations: the clinic, a community-based organization or at the patient’s home. Another option is directly observed therapy, which is an intensive program where individuals take one or more of their daily doses under the supervision of the adherence staff, either at the person’s home or the hospital.”

Squires said health professionals who work with HIV/AIDS patients never give up on those whose HIV becomes drug resistant.

“We continue to treat a person because we want to decrease the virus replication and help boost the immune system,” Squires said. “If a person becomes resistant to treatment medication, it’s better to continue a course of anti-HIV drugs than not treat the infection at all.

“Even with resistance there remains some benefit from treatment, as a person is less likely to develop an infection causing additional complications,” she said.

Recent advances in anti-HIV drugs have helped decrease the number of people combating resistance because the medications are easier to take and present fewer side effects than previous treatments.

“When we first started treating HIV many years ago, we were asking people to take three different drugs consisting of multiple pills that had to be taken multiple times each day,” Squires explained. “It isn’t surprising people ran into trouble and developed resistance, because the medication was so complicated to take.”

Squires is optimistic about what doctors will soon be able to offer patients.

“For physicians, the exciting news is we now have access to new agents in the clinical pipeline that are developed specifically for patients who harbor a resistant virus,” Squires said.

“Future developments will include medications that encompass all aspects of treatment into one pill. This is ideal because we can incorporate the treatment into a person’s lifestyle,” she said.

“If we’re not asking people to change their whole lifestyle, they have a much better chance at success.”


Story Source:

The above story is based on materials provided by University Of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University Of Southern California. "USC Teams Battle HIV Drug Resistance." ScienceDaily. ScienceDaily, 16 March 2005. <www.sciencedaily.com/releases/2005/03/050310105701.htm>.
University Of Southern California. (2005, March 16). USC Teams Battle HIV Drug Resistance. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2005/03/050310105701.htm
University Of Southern California. "USC Teams Battle HIV Drug Resistance." ScienceDaily. www.sciencedaily.com/releases/2005/03/050310105701.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins